Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chubb
Deloitte
AstraZeneca
Moodys
Covington
Healthtrust
McKesson
US Army

Generated: January 20, 2019

DrugPatentWatch Database Preview

Roxane Company Profile

« Back to Dashboard

What is the competitive landscape for ROXANE, and what generic and branded alternatives to ROXANE drugs are available?

ROXANE has one hundred and twenty-eight approved drugs.

There are fifteen tentative approvals on ROXANE drugs.

Drugs and US Patents for Roxane

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 084536-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Roxane METHADONE HYDROCHLORIDE methadone hydrochloride TABLET;ORAL 074081-001 Apr 28, 1995 DISCN No No ➤ Sign Up ➤ Sign Up
Roxane LAMOTRIGINE lamotrigine TABLET;ORAL 077392-004 Jan 27, 2009 DISCN No No ➤ Sign Up ➤ Sign Up
Roxane NEFAZODONE HYDROCHLORIDE nefazodone hydrochloride TABLET;ORAL 076196-001 Sep 16, 2003 DISCN No No ➤ Sign Up ➤ Sign Up
Roxane ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 086899-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Roxane TOPIRAMATE topiramate TABLET;ORAL 076306-001 Mar 27, 2009 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Colorcon
Farmers Insurance
McKesson
Dow
Harvard Business School
Chinese Patent Office
Moodys
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.